Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…
The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.
The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.
Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.
The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…
A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.
The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.
